Tag: CBT > International: Page 2

Canadian Cannabis Market

Cannara Expands International Supply Agreement With Curaleaf

The amended agreement has a potential aggregate contract value of approximately C$34 million over its two-year term.

October 6, 2026

Mergers and Acquisitions

Curaleaf Enhances Offer to Acquire Aurora Cannabis in Takeover Bid

The cannabis company increased the total implied consideration by 25% to US $5 per Aurora share, representing a premium of 86% to Aurora’s unaffected share price.

October 5, 2026

Canadian Cannabis Market

Rove Enters Canada With Ontario Launch

The leading U.S. cannabis vape brand marks first international expansion.

October 1, 2026

Mergers and Acquisitions

Aurora Cannabis Files Application With Alberta Securities Commission to Protect Company Shareholders

The company filed the application, having identified what it calls several deficiencies in Curaleaf’s hostile bid disclosure.

September 24, 2026

International

Canopy Growth Expands European Medical Cannabis Supply Into UK

The company will supply four Canadian-grown flower strains to distribute in the U.K. medical cannabis market under Spectrum Therapeutics.

September 22, 2026

Finance

Aurora Cannabis Provides Business Update

The company’s acquisition of Safari Flower and leading European performance are expected to fuel international growth in Q2 and beyond.

September 16, 2026

Mergers and Acquisitions

Curaleaf Sends Letter to Aurora Shareholders

Curaleaf Chairman and CEO Boris Jordan encourages Aurora’s shareholders to tender their shares and become owners of the world’s leading cannabis company.

September 15, 2026

Mergers and Acquisitions

Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From Facts

Aurora claims that Curaleaf’s latest announcement is a ‘desperate’ effort to shift shareholder attention away from a hostile bid that “undervalues’ Aurora.

September 14, 2026

Mergers and Acquisitions

Curaleaf Submits Application to Alberta Securities Commission to Halt Aurora's ATM Program During Pending Offer

The company argues Aurora’s share issuances are an improper and abusive defensive tactic that dilutes shareholders and interferes with the consideration of Curaleaf’s offer.

September 14, 2026

Mergers and Acquisitions

Curaleaf Issues Fact Sheet to Address What It Believes Are Misleading Statements From Aurora

The company’s fact sheet includes more than a dozen “myths” that it says Aurora has focused on while criticizing Curaleaf’s takeover bid.

September 8, 2026

Mergers and Acquisitions

Curaleaf Responds to Aurora Circular; Reaffirms Offer as Best Path to Value Creation for Shareholders

The company’s response comes after Aurora’s board unanimously concluded that the takeover bid is not in the best interests of Aurora or its shareholders.

September 2, 2026

Finance

Aurora Cannabis Urges Shareholders to Reject Curaleaf's Hostile Bid

The company is warning that the Curaleaf bid is inadequate, undervalues Aurora, and puts shareholder value and future upside at risk.

September 2, 2026